Article info

Download PDFPDF
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Authors

  1. Correspondence to Dr Emma Niméus, Department of Clinical Sciences Lund, Oncology and Pathology, Medicon Village, By 406, Lund SE-223 81, Sweden; Emma.Nimeus{at}med.lu.se
View Full Text

Citation

Sjöström M, Hartman L, Honeth G, et al
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Publication history

  • Received April 21, 2015
  • Revised June 16, 2015
  • Accepted June 22, 2015
  • First published July 14, 2015.
Online issue publication 
November 23, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.